SlideShare a Scribd company logo
Focus Fox
Many utility companies have introduced programs to encourage energy
conservation among their customers. An electric company considers
placing small digital displays in house holds to show current electricity
use and what the cost would be if this use continued for a month. Will
the displays reduce electricity use? One cheaper approach is to give
customers a chart and information about monitoring their electricity use
from their outside meter. Would this method work almost as well?
The company decides to conduct an experiment to compare these two
approaches (display, chart) with a control group of customers who
receive information about energy consumption but no help in
monitoring electricity use.
Outline a completely randomized design involving 60 households in the
same city willing to participate. Write a few sentences describing how
you would implement the design.
Good Experiment
Three Principles of Experimental Design
P2
• Control for lurking variables that might affect response variable
Use a comparative design and ensure that the only systematic
difference between groups is the treatment
• Random Assignment – chance accounts for variation among units
Use impersonal chance to assign experimental units to treatments.
This helps create roughly equivalent groups of experimental units
by balancing the effects of lurking variables that aren’t controlled
• Replication – you wouldn’t trust results of 1 student in each class
Use enough experimental units in each group so that any difference
in the effects of the treatments can be distinguished from chance
differences between groups. (use enough subjects)
Placebos
Does regularly taking aspirin help protect people against heart attacks?
The Physician’s Health Study was a medical experiment that helped
answer this question. In fact, the Physicians’ Health Study looked at
the effects of two drugs: aspirin and beta-carotene. Researchers
wondered whether beta-carotene would help prevent some forms of
cancer. The subjects in this experiment were 21,996 male physicians.
There were two explanatory variables (factors), each having two levels:
aspirin (yes or no) and beta-carotene (yes or no). Combinations of the
levels of these factors form the four treatments. One-fourth of the
subjects were assigned at random to each treatment.
Odd number days – aspirin or placebo
Even number days – beta-carotene or placebo
After several years, 239 vs. 139 of aspirin group suffered heart attacks
Experimental Design
Explain how each of the 3 principles of experimental design were used
in the study.

Pg. 242

The control group – the inactive treatment group (placebo)
* can be used to compare to the effects of aspirin alone, beta-carotene
alone, both, or none.
What can go Wrong?
ALL subjects MUST be treated identically
- pill
- cream
Many medical experiments are “placebo-controlled”
The response to an “dummy pill” treatment is called the placebo effect
Strength of placebo effect in medical treatments is hard to pin down
because it depends on exact environment, doctor’s attitude
Pg. 243
What can go Wrong?
If some subjects do not take a pill, the effect of aspirin or beta-carotene
would be confounded
If subjects know they are getting “just a placebo” it might weaken the
placebo effect and bias the experiment in favor of other treatments
If the doctors or other medical personnel know what treatment each
subject received, they may change how they interact & diagnose patients
To avoid anyone knowing who has what….
when experiments have human subjects, use a __________________
study.
-
What can go Wrong?
It may be impossible to perform a double blind study.
Such experiments can still be conducted as a single-blind study.

- Dieting and exercise
- Pill preventing Alzheimer's
Pg. 244 Check Your Understanding!

More Related Content

What's hot

Advanced statistical manual part i
Advanced statistical manual part iAdvanced statistical manual part i
Advanced statistical manual part i
Ayurdata
 
Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a lim...
Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a lim...Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a lim...
Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a lim...
ScHARR HEDS
 
Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinender
jinender16
 
Using Semantic Web Technologies to Reproduce a Pharmacovigilance Case Study
Using Semantic Web Technologies  to Reproduce  a Pharmacovigilance Case StudyUsing Semantic Web Technologies  to Reproduce  a Pharmacovigilance Case Study
Using Semantic Web Technologies to Reproduce a Pharmacovigilance Case Study
Jacco van Ossenbruggen
 
C:\Fakepath\Exeter Ppt Ppt New
C:\Fakepath\Exeter Ppt Ppt NewC:\Fakepath\Exeter Ppt Ppt New
C:\Fakepath\Exeter Ppt Ppt New
Reinhard Wentz
 
Headaches still evident in migraine market
Headaches still evident in migraine marketHeadaches still evident in migraine market
Headaches still evident in migraine market
Bloomberg LP
 
Indian j medres1262167-2621692_071656
Indian j medres1262167-2621692_071656Indian j medres1262167-2621692_071656
Indian j medres1262167-2621692_071656
Susmit Jain
 
Epi pen inspire 2012[1] (melinda hamilton)
Epi pen inspire 2012[1] (melinda hamilton)Epi pen inspire 2012[1] (melinda hamilton)
Epi pen inspire 2012[1] (melinda hamilton)
INSPIRE_Network
 
Experimental design cartoon part 5 sample size
Experimental design cartoon part 5 sample sizeExperimental design cartoon part 5 sample size
Experimental design cartoon part 5 sample size
Kevin Hamill
 
Understanding Drug Resistance
Understanding Drug ResistanceUnderstanding Drug Resistance
Understanding Drug Resistance
dwinter1
 

What's hot (10)

Advanced statistical manual part i
Advanced statistical manual part iAdvanced statistical manual part i
Advanced statistical manual part i
 
Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a lim...
Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a lim...Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a lim...
Estimating EQ-5D health state values for Rheumatoid Arthritis patients: a lim...
 
Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinender
 
Using Semantic Web Technologies to Reproduce a Pharmacovigilance Case Study
Using Semantic Web Technologies  to Reproduce  a Pharmacovigilance Case StudyUsing Semantic Web Technologies  to Reproduce  a Pharmacovigilance Case Study
Using Semantic Web Technologies to Reproduce a Pharmacovigilance Case Study
 
C:\Fakepath\Exeter Ppt Ppt New
C:\Fakepath\Exeter Ppt Ppt NewC:\Fakepath\Exeter Ppt Ppt New
C:\Fakepath\Exeter Ppt Ppt New
 
Headaches still evident in migraine market
Headaches still evident in migraine marketHeadaches still evident in migraine market
Headaches still evident in migraine market
 
Indian j medres1262167-2621692_071656
Indian j medres1262167-2621692_071656Indian j medres1262167-2621692_071656
Indian j medres1262167-2621692_071656
 
Epi pen inspire 2012[1] (melinda hamilton)
Epi pen inspire 2012[1] (melinda hamilton)Epi pen inspire 2012[1] (melinda hamilton)
Epi pen inspire 2012[1] (melinda hamilton)
 
Experimental design cartoon part 5 sample size
Experimental design cartoon part 5 sample sizeExperimental design cartoon part 5 sample size
Experimental design cartoon part 5 sample size
 
Understanding Drug Resistance
Understanding Drug ResistanceUnderstanding Drug Resistance
Understanding Drug Resistance
 

Viewers also liked

Kerrang
KerrangKerrang
Kerrang
CharleyX
 
Beadandó házidolgozat Zakor Dániel János
Beadandó házidolgozat Zakor Dániel JánosBeadandó házidolgozat Zakor Dániel János
Beadandó házidolgozat Zakor Dániel Jánoszakordani
 
Little Talks - The Narrative Arc
Little Talks - The Narrative ArcLittle Talks - The Narrative Arc
Little Talks - The Narrative Arc
CharleyX
 
Music Magazine pitch
Music Magazine pitchMusic Magazine pitch
Music Magazine pitch
CharleyX
 
Presentacion Cargo logisticolombia
Presentacion Cargo logisticolombiaPresentacion Cargo logisticolombia
Presentacion Cargo logisticolombiaDiana Fajardo
 
Stereotypes Of Homosexuals
Stereotypes Of HomosexualsStereotypes Of Homosexuals
Stereotypes Of Homosexuals
CharleyX
 
Es deia Vanessa. On es ara?
Es deia Vanessa. On es ara?Es deia Vanessa. On es ara?
Es deia Vanessa. On es ara?joanvayreda
 
Little Talks - The Narrative Arc
Little Talks - The Narrative ArcLittle Talks - The Narrative Arc
Little Talks - The Narrative Arc
CharleyX
 
Es deia Vanessa. On es ara?
Es deia Vanessa. On es ara?Es deia Vanessa. On es ara?
Es deia Vanessa. On es ara?joanvayreda
 
Analysis of "This Is Gospel" by Panic! At The Disco
Analysis of "This Is Gospel" by Panic! At The Disco Analysis of "This Is Gospel" by Panic! At The Disco
Analysis of "This Is Gospel" by Panic! At The Disco
CharleyX
 
Driving Design through Examples
Driving Design through ExamplesDriving Design through Examples
Driving Design through Examples
CiaranMcNulty
 
Chi square test for homgeneity
Chi square test for homgeneityChi square test for homgeneity
Chi square test for homgeneity
amylute
 
Logarithmic transformations
Logarithmic transformationsLogarithmic transformations
Logarithmic transformations
amylute
 
Regression inference confidence intervals
Regression inference confidence intervalsRegression inference confidence intervals
Regression inference confidence intervals
amylute
 

Viewers also liked (14)

Kerrang
KerrangKerrang
Kerrang
 
Beadandó házidolgozat Zakor Dániel János
Beadandó házidolgozat Zakor Dániel JánosBeadandó házidolgozat Zakor Dániel János
Beadandó házidolgozat Zakor Dániel János
 
Little Talks - The Narrative Arc
Little Talks - The Narrative ArcLittle Talks - The Narrative Arc
Little Talks - The Narrative Arc
 
Music Magazine pitch
Music Magazine pitchMusic Magazine pitch
Music Magazine pitch
 
Presentacion Cargo logisticolombia
Presentacion Cargo logisticolombiaPresentacion Cargo logisticolombia
Presentacion Cargo logisticolombia
 
Stereotypes Of Homosexuals
Stereotypes Of HomosexualsStereotypes Of Homosexuals
Stereotypes Of Homosexuals
 
Es deia Vanessa. On es ara?
Es deia Vanessa. On es ara?Es deia Vanessa. On es ara?
Es deia Vanessa. On es ara?
 
Little Talks - The Narrative Arc
Little Talks - The Narrative ArcLittle Talks - The Narrative Arc
Little Talks - The Narrative Arc
 
Es deia Vanessa. On es ara?
Es deia Vanessa. On es ara?Es deia Vanessa. On es ara?
Es deia Vanessa. On es ara?
 
Analysis of "This Is Gospel" by Panic! At The Disco
Analysis of "This Is Gospel" by Panic! At The Disco Analysis of "This Is Gospel" by Panic! At The Disco
Analysis of "This Is Gospel" by Panic! At The Disco
 
Driving Design through Examples
Driving Design through ExamplesDriving Design through Examples
Driving Design through Examples
 
Chi square test for homgeneity
Chi square test for homgeneityChi square test for homgeneity
Chi square test for homgeneity
 
Logarithmic transformations
Logarithmic transformationsLogarithmic transformations
Logarithmic transformations
 
Regression inference confidence intervals
Regression inference confidence intervalsRegression inference confidence intervals
Regression inference confidence intervals
 

Similar to 4.2 placebos & double blind

Mpharm RA 103.pdf
Mpharm RA 103.pdfMpharm RA 103.pdf
Mpharm RA 103.pdf
Zeelshah2258
 
Research Design
Research DesignResearch Design
Research Design
Sathish Rajamani
 
Evidence-Based Nutrition Practice - Critical Appraisal
Evidence-Based Nutrition Practice - Critical AppraisalEvidence-Based Nutrition Practice - Critical Appraisal
Evidence-Based Nutrition Practice - Critical Appraisal
Rachel Hinrichs
 
4.2 Experiments.pptx
4.2 Experiments.pptx4.2 Experiments.pptx
4.2 Experiments.pptx
PhcNguyn449154
 
1. Week 5 Assignment - Case Study Statistical ForecastingDr.
1. Week 5 Assignment - Case Study Statistical ForecastingDr. 1. Week 5 Assignment - Case Study Statistical ForecastingDr.
1. Week 5 Assignment - Case Study Statistical ForecastingDr.
TatianaMajor22
 
Choice of control group in clinical trials
Choice of control group in clinical trialsChoice of control group in clinical trials
Choice of control group in clinical trials
Nagendra SR
 
E4 GUIDELINE DOSE RESPONSE INFORMATION TO SUPPORT DRUG REGISTRATION
E4 GUIDELINE DOSE RESPONSE INFORMATION TO SUPPORT DRUG REGISTRATIONE4 GUIDELINE DOSE RESPONSE INFORMATION TO SUPPORT DRUG REGISTRATION
E4 GUIDELINE DOSE RESPONSE INFORMATION TO SUPPORT DRUG REGISTRATION
Charmi13
 
Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population
Shubham Chinchulkar
 
1.3 Experimental Design and Observational Studies
1.3 Experimental Design and Observational Studies 1.3 Experimental Design and Observational Studies
1.3 Experimental Design and Observational Studies
MaryWall14
 
Sec 1.3 collecting sample data
Sec 1.3 collecting sample data  Sec 1.3 collecting sample data
Sec 1.3 collecting sample data
Long Beach City College
 
ACDRS Talk Tamura Oct 2009 1
ACDRS Talk Tamura  Oct 2009 1ACDRS Talk Tamura  Oct 2009 1
ACDRS Talk Tamura Oct 2009 1
rm60553
 
BABE Study Designes.pptx
BABE Study Designes.pptxBABE Study Designes.pptx
BABE Study Designes.pptx
MubarakAhmad28
 
Evidencia en el tratamiento 2013
Evidencia en el tratamiento 2013Evidencia en el tratamiento 2013
Evidencia en el tratamiento 2013
Residentes1hun
 
Notes Ch13
Notes Ch13Notes Ch13
Notes Ch13
jmalpass
 
ich guidelines for clinical trials, scientific approach ppt.pptx
ich guidelines for clinical trials, scientific approach ppt.pptxich guidelines for clinical trials, scientific approach ppt.pptx
ich guidelines for clinical trials, scientific approach ppt.pptx
JyotshnaDevi4
 
Health Care Systems Policy.docx
Health Care Systems Policy.docxHealth Care Systems Policy.docx
Health Care Systems Policy.docx
write12
 
Health Care Systems Policy.docx
Health Care Systems Policy.docxHealth Care Systems Policy.docx
Health Care Systems Policy.docx
write4
 
Writing a lab report
Writing a lab reportWriting a lab report
Writing a lab report
ArashPreet3
 
Writing a lab report
Writing a lab reportWriting a lab report
Writing a lab report
ArashPreet3
 
Experimental designs .pptx
 Experimental designs .pptx Experimental designs .pptx
Experimental designs .pptx
Chinna Chadayan
 

Similar to 4.2 placebos & double blind (20)

Mpharm RA 103.pdf
Mpharm RA 103.pdfMpharm RA 103.pdf
Mpharm RA 103.pdf
 
Research Design
Research DesignResearch Design
Research Design
 
Evidence-Based Nutrition Practice - Critical Appraisal
Evidence-Based Nutrition Practice - Critical AppraisalEvidence-Based Nutrition Practice - Critical Appraisal
Evidence-Based Nutrition Practice - Critical Appraisal
 
4.2 Experiments.pptx
4.2 Experiments.pptx4.2 Experiments.pptx
4.2 Experiments.pptx
 
1. Week 5 Assignment - Case Study Statistical ForecastingDr.
1. Week 5 Assignment - Case Study Statistical ForecastingDr. 1. Week 5 Assignment - Case Study Statistical ForecastingDr.
1. Week 5 Assignment - Case Study Statistical ForecastingDr.
 
Choice of control group in clinical trials
Choice of control group in clinical trialsChoice of control group in clinical trials
Choice of control group in clinical trials
 
E4 GUIDELINE DOSE RESPONSE INFORMATION TO SUPPORT DRUG REGISTRATION
E4 GUIDELINE DOSE RESPONSE INFORMATION TO SUPPORT DRUG REGISTRATIONE4 GUIDELINE DOSE RESPONSE INFORMATION TO SUPPORT DRUG REGISTRATION
E4 GUIDELINE DOSE RESPONSE INFORMATION TO SUPPORT DRUG REGISTRATION
 
Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population Clinical trial design, Trial Size, and Study Population
Clinical trial design, Trial Size, and Study Population
 
1.3 Experimental Design and Observational Studies
1.3 Experimental Design and Observational Studies 1.3 Experimental Design and Observational Studies
1.3 Experimental Design and Observational Studies
 
Sec 1.3 collecting sample data
Sec 1.3 collecting sample data  Sec 1.3 collecting sample data
Sec 1.3 collecting sample data
 
ACDRS Talk Tamura Oct 2009 1
ACDRS Talk Tamura  Oct 2009 1ACDRS Talk Tamura  Oct 2009 1
ACDRS Talk Tamura Oct 2009 1
 
BABE Study Designes.pptx
BABE Study Designes.pptxBABE Study Designes.pptx
BABE Study Designes.pptx
 
Evidencia en el tratamiento 2013
Evidencia en el tratamiento 2013Evidencia en el tratamiento 2013
Evidencia en el tratamiento 2013
 
Notes Ch13
Notes Ch13Notes Ch13
Notes Ch13
 
ich guidelines for clinical trials, scientific approach ppt.pptx
ich guidelines for clinical trials, scientific approach ppt.pptxich guidelines for clinical trials, scientific approach ppt.pptx
ich guidelines for clinical trials, scientific approach ppt.pptx
 
Health Care Systems Policy.docx
Health Care Systems Policy.docxHealth Care Systems Policy.docx
Health Care Systems Policy.docx
 
Health Care Systems Policy.docx
Health Care Systems Policy.docxHealth Care Systems Policy.docx
Health Care Systems Policy.docx
 
Writing a lab report
Writing a lab reportWriting a lab report
Writing a lab report
 
Writing a lab report
Writing a lab reportWriting a lab report
Writing a lab report
 
Experimental designs .pptx
 Experimental designs .pptx Experimental designs .pptx
Experimental designs .pptx
 

More from amylute

What are the odds notes
What are the odds notesWhat are the odds notes
What are the odds notes
amylute
 
Transforming data for inference
Transforming data for inferenceTransforming data for inference
Transforming data for inference
amylute
 
Inference in regression line test
Inference  in regression line testInference  in regression line test
Inference in regression line test
amylute
 
Using chi square wisely
Using chi square wiselyUsing chi square wisely
Using chi square wisely
amylute
 
Relationships across distribution
Relationships across distributionRelationships across distribution
Relationships across distribution
amylute
 
Chi square goodness of fit test
Chi square goodness of fit testChi square goodness of fit test
Chi square goodness of fit test
amylute
 
Chi square distribution table c
Chi square distribution table cChi square distribution table c
Chi square distribution table c
amylute
 
Ap statistics chp. 11
Ap statistics chp. 11Ap statistics chp. 11
Ap statistics chp. 11
amylute
 
Dividing polys
Dividing polysDividing polys
Dividing polys
amylute
 
Solving triangles pp slides
Solving triangles pp slidesSolving triangles pp slides
Solving triangles pp slides
amylute
 
Conditional prob & independence
Conditional prob & independenceConditional prob & independence
Conditional prob & independence
amylute
 
Two way tables & venn diagrams
Two way tables & venn diagramsTwo way tables & venn diagrams
Two way tables & venn diagrams
amylute
 
Probability models & basic rules
Probability models & basic rulesProbability models & basic rules
Probability models & basic rules
amylute
 
Simulation
SimulationSimulation
Simulation
amylute
 
Mthys of probability
Mthys of probabilityMthys of probability
Mthys of probability
amylute
 
4.3 using studies wisely
4.3 using studies wisely4.3 using studies wisely
4.3 using studies wisely
amylute
 
4.2 blocking
4.2 blocking4.2 blocking
4.2 blocking
amylute
 
4.2 good vs. bad exp
4.2 good vs. bad exp4.2 good vs. bad exp
4.2 good vs. bad expamylute
 

More from amylute (18)

What are the odds notes
What are the odds notesWhat are the odds notes
What are the odds notes
 
Transforming data for inference
Transforming data for inferenceTransforming data for inference
Transforming data for inference
 
Inference in regression line test
Inference  in regression line testInference  in regression line test
Inference in regression line test
 
Using chi square wisely
Using chi square wiselyUsing chi square wisely
Using chi square wisely
 
Relationships across distribution
Relationships across distributionRelationships across distribution
Relationships across distribution
 
Chi square goodness of fit test
Chi square goodness of fit testChi square goodness of fit test
Chi square goodness of fit test
 
Chi square distribution table c
Chi square distribution table cChi square distribution table c
Chi square distribution table c
 
Ap statistics chp. 11
Ap statistics chp. 11Ap statistics chp. 11
Ap statistics chp. 11
 
Dividing polys
Dividing polysDividing polys
Dividing polys
 
Solving triangles pp slides
Solving triangles pp slidesSolving triangles pp slides
Solving triangles pp slides
 
Conditional prob & independence
Conditional prob & independenceConditional prob & independence
Conditional prob & independence
 
Two way tables & venn diagrams
Two way tables & venn diagramsTwo way tables & venn diagrams
Two way tables & venn diagrams
 
Probability models & basic rules
Probability models & basic rulesProbability models & basic rules
Probability models & basic rules
 
Simulation
SimulationSimulation
Simulation
 
Mthys of probability
Mthys of probabilityMthys of probability
Mthys of probability
 
4.3 using studies wisely
4.3 using studies wisely4.3 using studies wisely
4.3 using studies wisely
 
4.2 blocking
4.2 blocking4.2 blocking
4.2 blocking
 
4.2 good vs. bad exp
4.2 good vs. bad exp4.2 good vs. bad exp
4.2 good vs. bad exp
 

Recently uploaded

Recommendation System using RAG Architecture
Recommendation System using RAG ArchitectureRecommendation System using RAG Architecture
Recommendation System using RAG Architecture
fredae14
 
TrustArc Webinar - 2024 Global Privacy Survey
TrustArc Webinar - 2024 Global Privacy SurveyTrustArc Webinar - 2024 Global Privacy Survey
TrustArc Webinar - 2024 Global Privacy Survey
TrustArc
 
Your One-Stop Shop for Python Success: Top 10 US Python Development Providers
Your One-Stop Shop for Python Success: Top 10 US Python Development ProvidersYour One-Stop Shop for Python Success: Top 10 US Python Development Providers
Your One-Stop Shop for Python Success: Top 10 US Python Development Providers
akankshawande
 
Building Production Ready Search Pipelines with Spark and Milvus
Building Production Ready Search Pipelines with Spark and MilvusBuilding Production Ready Search Pipelines with Spark and Milvus
Building Production Ready Search Pipelines with Spark and Milvus
Zilliz
 
Monitoring and Managing Anomaly Detection on OpenShift.pdf
Monitoring and Managing Anomaly Detection on OpenShift.pdfMonitoring and Managing Anomaly Detection on OpenShift.pdf
Monitoring and Managing Anomaly Detection on OpenShift.pdf
Tosin Akinosho
 
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with SlackLet's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
shyamraj55
 
Generating privacy-protected synthetic data using Secludy and Milvus
Generating privacy-protected synthetic data using Secludy and MilvusGenerating privacy-protected synthetic data using Secludy and Milvus
Generating privacy-protected synthetic data using Secludy and Milvus
Zilliz
 
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
AI 101: An Introduction to the Basics and Impact of Artificial IntelligenceAI 101: An Introduction to the Basics and Impact of Artificial Intelligence
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
IndexBug
 
Digital Marketing Trends in 2024 | Guide for Staying Ahead
Digital Marketing Trends in 2024 | Guide for Staying AheadDigital Marketing Trends in 2024 | Guide for Staying Ahead
Digital Marketing Trends in 2024 | Guide for Staying Ahead
Wask
 
Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...
Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...
Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...
saastr
 
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
名前 です男
 
20240607 QFM018 Elixir Reading List May 2024
20240607 QFM018 Elixir Reading List May 202420240607 QFM018 Elixir Reading List May 2024
20240607 QFM018 Elixir Reading List May 2024
Matthew Sinclair
 
Artificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopmentArtificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopment
Octavian Nadolu
 
GenAI Pilot Implementation in the organizations
GenAI Pilot Implementation in the organizationsGenAI Pilot Implementation in the organizations
GenAI Pilot Implementation in the organizations
kumardaparthi1024
 
Columbus Data & Analytics Wednesdays - June 2024
Columbus Data & Analytics Wednesdays - June 2024Columbus Data & Analytics Wednesdays - June 2024
Columbus Data & Analytics Wednesdays - June 2024
Jason Packer
 
Salesforce Integration for Bonterra Impact Management (fka Social Solutions A...
Salesforce Integration for Bonterra Impact Management (fka Social Solutions A...Salesforce Integration for Bonterra Impact Management (fka Social Solutions A...
Salesforce Integration for Bonterra Impact Management (fka Social Solutions A...
Jeffrey Haguewood
 
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdfUnlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Malak Abu Hammad
 
Choosing The Best AWS Service For Your Website + API.pptx
Choosing The Best AWS Service For Your Website + API.pptxChoosing The Best AWS Service For Your Website + API.pptx
Choosing The Best AWS Service For Your Website + API.pptx
Brandon Minnick, MBA
 
Introduction of Cybersecurity with OSS at Code Europe 2024
Introduction of Cybersecurity with OSS  at Code Europe 2024Introduction of Cybersecurity with OSS  at Code Europe 2024
Introduction of Cybersecurity with OSS at Code Europe 2024
Hiroshi SHIBATA
 
Programming Foundation Models with DSPy - Meetup Slides
Programming Foundation Models with DSPy - Meetup SlidesProgramming Foundation Models with DSPy - Meetup Slides
Programming Foundation Models with DSPy - Meetup Slides
Zilliz
 

Recently uploaded (20)

Recommendation System using RAG Architecture
Recommendation System using RAG ArchitectureRecommendation System using RAG Architecture
Recommendation System using RAG Architecture
 
TrustArc Webinar - 2024 Global Privacy Survey
TrustArc Webinar - 2024 Global Privacy SurveyTrustArc Webinar - 2024 Global Privacy Survey
TrustArc Webinar - 2024 Global Privacy Survey
 
Your One-Stop Shop for Python Success: Top 10 US Python Development Providers
Your One-Stop Shop for Python Success: Top 10 US Python Development ProvidersYour One-Stop Shop for Python Success: Top 10 US Python Development Providers
Your One-Stop Shop for Python Success: Top 10 US Python Development Providers
 
Building Production Ready Search Pipelines with Spark and Milvus
Building Production Ready Search Pipelines with Spark and MilvusBuilding Production Ready Search Pipelines with Spark and Milvus
Building Production Ready Search Pipelines with Spark and Milvus
 
Monitoring and Managing Anomaly Detection on OpenShift.pdf
Monitoring and Managing Anomaly Detection on OpenShift.pdfMonitoring and Managing Anomaly Detection on OpenShift.pdf
Monitoring and Managing Anomaly Detection on OpenShift.pdf
 
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with SlackLet's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
 
Generating privacy-protected synthetic data using Secludy and Milvus
Generating privacy-protected synthetic data using Secludy and MilvusGenerating privacy-protected synthetic data using Secludy and Milvus
Generating privacy-protected synthetic data using Secludy and Milvus
 
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
AI 101: An Introduction to the Basics and Impact of Artificial IntelligenceAI 101: An Introduction to the Basics and Impact of Artificial Intelligence
AI 101: An Introduction to the Basics and Impact of Artificial Intelligence
 
Digital Marketing Trends in 2024 | Guide for Staying Ahead
Digital Marketing Trends in 2024 | Guide for Staying AheadDigital Marketing Trends in 2024 | Guide for Staying Ahead
Digital Marketing Trends in 2024 | Guide for Staying Ahead
 
Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...
Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...
Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...
 
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
 
20240607 QFM018 Elixir Reading List May 2024
20240607 QFM018 Elixir Reading List May 202420240607 QFM018 Elixir Reading List May 2024
20240607 QFM018 Elixir Reading List May 2024
 
Artificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopmentArtificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopment
 
GenAI Pilot Implementation in the organizations
GenAI Pilot Implementation in the organizationsGenAI Pilot Implementation in the organizations
GenAI Pilot Implementation in the organizations
 
Columbus Data & Analytics Wednesdays - June 2024
Columbus Data & Analytics Wednesdays - June 2024Columbus Data & Analytics Wednesdays - June 2024
Columbus Data & Analytics Wednesdays - June 2024
 
Salesforce Integration for Bonterra Impact Management (fka Social Solutions A...
Salesforce Integration for Bonterra Impact Management (fka Social Solutions A...Salesforce Integration for Bonterra Impact Management (fka Social Solutions A...
Salesforce Integration for Bonterra Impact Management (fka Social Solutions A...
 
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdfUnlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
 
Choosing The Best AWS Service For Your Website + API.pptx
Choosing The Best AWS Service For Your Website + API.pptxChoosing The Best AWS Service For Your Website + API.pptx
Choosing The Best AWS Service For Your Website + API.pptx
 
Introduction of Cybersecurity with OSS at Code Europe 2024
Introduction of Cybersecurity with OSS  at Code Europe 2024Introduction of Cybersecurity with OSS  at Code Europe 2024
Introduction of Cybersecurity with OSS at Code Europe 2024
 
Programming Foundation Models with DSPy - Meetup Slides
Programming Foundation Models with DSPy - Meetup SlidesProgramming Foundation Models with DSPy - Meetup Slides
Programming Foundation Models with DSPy - Meetup Slides
 

4.2 placebos & double blind

  • 1. Focus Fox Many utility companies have introduced programs to encourage energy conservation among their customers. An electric company considers placing small digital displays in house holds to show current electricity use and what the cost would be if this use continued for a month. Will the displays reduce electricity use? One cheaper approach is to give customers a chart and information about monitoring their electricity use from their outside meter. Would this method work almost as well? The company decides to conduct an experiment to compare these two approaches (display, chart) with a control group of customers who receive information about energy consumption but no help in monitoring electricity use. Outline a completely randomized design involving 60 households in the same city willing to participate. Write a few sentences describing how you would implement the design.
  • 2. Good Experiment Three Principles of Experimental Design P2 • Control for lurking variables that might affect response variable Use a comparative design and ensure that the only systematic difference between groups is the treatment • Random Assignment – chance accounts for variation among units Use impersonal chance to assign experimental units to treatments. This helps create roughly equivalent groups of experimental units by balancing the effects of lurking variables that aren’t controlled • Replication – you wouldn’t trust results of 1 student in each class Use enough experimental units in each group so that any difference in the effects of the treatments can be distinguished from chance differences between groups. (use enough subjects)
  • 3. Placebos Does regularly taking aspirin help protect people against heart attacks? The Physician’s Health Study was a medical experiment that helped answer this question. In fact, the Physicians’ Health Study looked at the effects of two drugs: aspirin and beta-carotene. Researchers wondered whether beta-carotene would help prevent some forms of cancer. The subjects in this experiment were 21,996 male physicians. There were two explanatory variables (factors), each having two levels: aspirin (yes or no) and beta-carotene (yes or no). Combinations of the levels of these factors form the four treatments. One-fourth of the subjects were assigned at random to each treatment. Odd number days – aspirin or placebo Even number days – beta-carotene or placebo After several years, 239 vs. 139 of aspirin group suffered heart attacks
  • 4. Experimental Design Explain how each of the 3 principles of experimental design were used in the study. Pg. 242 The control group – the inactive treatment group (placebo) * can be used to compare to the effects of aspirin alone, beta-carotene alone, both, or none.
  • 5. What can go Wrong? ALL subjects MUST be treated identically - pill - cream Many medical experiments are “placebo-controlled” The response to an “dummy pill” treatment is called the placebo effect Strength of placebo effect in medical treatments is hard to pin down because it depends on exact environment, doctor’s attitude Pg. 243
  • 6. What can go Wrong? If some subjects do not take a pill, the effect of aspirin or beta-carotene would be confounded If subjects know they are getting “just a placebo” it might weaken the placebo effect and bias the experiment in favor of other treatments If the doctors or other medical personnel know what treatment each subject received, they may change how they interact & diagnose patients To avoid anyone knowing who has what…. when experiments have human subjects, use a __________________ study. -
  • 7. What can go Wrong? It may be impossible to perform a double blind study. Such experiments can still be conducted as a single-blind study. - Dieting and exercise - Pill preventing Alzheimer's Pg. 244 Check Your Understanding!